The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AC IMMUNE SA | SHS | H00263105 | 663,816 | 325,400 | SH | SOLE | 0 | 325,400 | 0 | 0 | ||
ACADIA HEALTHCARE COMPANY IN | COM | 00404A109 | 95,902,800 | 1,165,000 | SH | SOLE | 0 | 1,165,000 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 209,610,000 | 3,825,000 | SH | SOLE | 0 | 3,825,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 7,557,270 | 1,028,200 | SH | SOLE | 0 | 1,028,200 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 65,635,500 | 3,990,000 | SH | SOLE | 0 | 3,990,000 | 0 | 0 | ||
AN2 THERAPEUTICS INC | COM | 037326105 | 7,086,508 | 743,600 | SH | SOLE | 0 | 743,600 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 25,974,000 | 1,755,000 | SH | SOLE | 0 | 1,755,000 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 236,768,750 | 625,000 | SH | SOLE | 0 | 625,000 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 55,770,000 | 1,375,000 | SH | SOLE | 0 | 1,375,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 169,339,500 | 4,950,000 | SH | SOLE | 0 | 4,950,000 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 5,050,000 | 500,000 | SH | SOLE | 0 | 500,000 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 81,360,000 | 1,200,000 | SH | SOLE | 0 | 1,200,000 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 72,672,250 | 3,275,000 | SH | SOLE | 0 | 3,275,000 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 51,677,100 | 670,000 | SH | SOLE | 0 | 670,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 37,811,984 | 4,599,998 | SH | SOLE | 0 | 4,599,998 | 0 | 0 | ||
BIO RAD LABS INC | CL A | 090572207 | 38,769,178 | 92,200 | SH | SOLE | 0 | 92,200 | 0 | 0 | ||
BIOATLA INC | COM | 09077B104 | 10,395,000 | 1,260,000 | SH | SOLE | 0 | 1,260,000 | 0 | 0 | ||
BIOHAVEN LTD | COM | G1110E107 | 20,708,960 | 1,492,000 | SH | SOLE | 0 | 1,492,000 | 0 | 0 | ||
BIONTECH SE | SPONSORED ADS | 09075V102 | 32,357,388 | 215,400 | SH | SOLE | 0 | 215,400 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 150,687,509 | 3,256,700 | SH | SOLE | 0 | 3,256,700 | 0 | 0 | ||
CAREMAX INC | COM CL A | 14171W103 | 2,756,951 | 755,329 | SH | SOLE | 0 | 755,329 | 0 | 0 | ||
CARIBOU BIOSCIENCES INC | COM | 142038108 | 18,102,728 | 2,882,600 | SH | SOLE | 0 | 2,882,600 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 6,687,468 | 1,303,600 | SH | SOLE | 0 | 1,303,600 | 0 | 0 | ||
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 879,234 | 37,898 | SH | SOLE | 0 | 37,898 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 10,060,000 | 2,000,000 | SH | SOLE | 0 | 2,000,000 | 0 | 0 | ||
CYTEIR THERAPEUTICS INC | COM | 23284P103 | 2,963,070 | 1,795,800 | SH | SOLE | 0 | 1,795,800 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 19,276,474 | 420,700 | SH | SOLE | 0 | 420,700 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 18,455,140 | 1,126,000 | SH | SOLE | 0 | 1,126,000 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 85,700,032 | 756,800 | SH | SOLE | 0 | 756,800 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 4,675,608 | 1,855,400 | SH | SOLE | 0 | 1,855,400 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 1,055,949 | 104,653 | SH | SOLE | 0 | 104,653 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 5,229,000 | 1,575,000 | SH | SOLE | 0 | 1,575,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 3,992,000 | 400,000 | SH | SOLE | 0 | 400,000 | 0 | 0 | ||
HYPERFINE INC | COM CL A | 44916K106 | 1,263,153 | 1,503,754 | SH | SOLE | 0 | 1,503,754 | 0 | 0 | ||
ICON PLC | SHS | G4705A100 | 41,763,750 | 215,000 | SH | SOLE | 0 | 215,000 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 69,496,616 | 3,824,800 | SH | SOLE | 0 | 3,824,800 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 65,858,780 | 1,154,000 | SH | SOLE | 0 | 1,154,000 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 22,266,798 | 638,200 | SH | SOLE | 0 | 638,200 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 26,671,680 | 504,000 | SH | SOLE | 0 | 504,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 17,950,294 | 838,407 | SH | SOLE | 0 | 838,407 | 0 | 0 | ||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 115,904,557 | 727,541 | SH | SOLE | 0 | 727,541 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 58,753,500 | 299,000 | SH | SOLE | 0 | 299,000 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 32,755,297 | 9,633,911 | SH | SOLE | 0 | 9,633,911 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 47,748,096 | 6,782,400 | SH | SOLE | 0 | 6,782,400 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 7,397,470 | 1,212,700 | SH | SOLE | 0 | 1,212,700 | 0 | 0 | ||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 48,422,400 | 970,000 | SH | SOLE | 0 | 970,000 | 0 | 0 | ||
LILLY ELI & CO | COM | 532457108 | 79,387,280 | 217,000 | SH | SOLE | 0 | 217,000 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 124,807,500 | 430,000 | SH | SOLE | 0 | 430,000 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 5,236,400 | 520,000 | SH | SOLE | 0 | 520,000 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 5,199 | 57,770 | SH | SOLE | 0 | 57,770 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 16,395,884 | 2,057,200 | SH | SOLE | 0 | 2,057,200 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 72,261,813 | 1,798,900 | SH | SOLE | 0 | 1,798,900 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 212,603,200 | 1,780,000 | SH | SOLE | 0 | 1,780,000 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 14,450 | 99,999 | SH | SOLE | 0 | 99,999 | 0 | 0 | ||
PANACEA ACQUISITION CORP II | CL A SHS | G6882C106 | 5,025,000 | 500,000 | SH | SOLE | 0 | 500,000 | 0 | 0 | ||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 21,318,000 | 1,900,000 | SH | SOLE | 0 | 1,900,000 | 0 | 0 | ||
PLIANT THERAPEUTICS INC | COM | 729139105 | 43,306,932 | 2,240,400 | SH | SOLE | 0 | 2,240,400 | 0 | 0 | ||
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 17,732,196 | 2,432,400 | SH | SOLE | 0 | 2,432,400 | 0 | 0 | ||
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 22,440,000 | 204,000 | SH | SOLE | 0 | 204,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 177,918,250 | 2,953,000 | SH | SOLE | 0 | 2,953,000 | 0 | 0 | ||
QUEST DIAGNOSTICS INC | COM | 74834L100 | 40,361,520 | 258,000 | SH | SOLE | 0 | 258,000 | 0 | 0 | ||
REUNION NEUROSCIENCE INC | COM | 76134G103 | 504,270 | 560,300 | SH | SOLE | 0 | 560,300 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 58,954,500 | 2,475,000 | SH | SOLE | 0 | 2,475,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 29,885,093 | 1,527,087 | SH | SOLE | 0 | 1,527,087 | 0 | 0 | ||
SANGAMO THERAPEUTICS INC | COM | 800677106 | 8,629,662 | 2,748,300 | SH | SOLE | 0 | 2,748,300 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 136,706,900 | 1,055,000 | SH | SOLE | 0 | 1,055,000 | 0 | 0 | ||
SCYNEXIS INC | COM NEW | 811292200 | 1,779,336 | 1,140,600 | SH | SOLE | 0 | 1,140,600 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CP | CLASS A ORD SHS | G8253Y105 | 2,010,000 | 200,000 | SH | SOLE | 0 | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253U103 | 2,012,000 | 200,000 | SH | SOLE | 0 | 200,000 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 337,146,000 | 4,062,000 | SH | Call | SOLE | 0 | 4,062,000 | 0 | 0 | |
SURGERY PARTNERS INC | COM | 86881A100 | 86,700,320 | 3,112,000 | SH | SOLE | 0 | 3,112,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 149,162,450 | 5,861,000 | SH | SOLE | 0 | 5,861,000 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 3,231,000 | 900,000 | SH | SOLE | 0 | 900,000 | 0 | 0 | ||
TENET HEALTHCARE CORP | COM NEW | 88033G407 | 34,997,067 | 717,300 | SH | SOLE | 0 | 717,300 | 0 | 0 | ||
TWIST BIOSCIENCE CORP | COM | 90184D100 | 14,547,910 | 611,000 | SH | SOLE | 0 | 611,000 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 138,526,700 | 2,990,000 | SH | SOLE | 0 | 2,990,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 218,439,695 | 785,500 | SH | SOLE | 0 | 785,500 | 0 | 0 | ||
UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 116,318,784 | 825,600 | SH | SOLE | 0 | 825,600 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 77,458,430 | 1,615,400 | SH | SOLE | 0 | 1,615,400 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 42,135,150 | 1,285,000 | SH | SOLE | 0 | 1,285,000 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 49,670,160 | 172,000 | SH | SOLE | 0 | 172,000 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 30,282,750 | 1,565,000 | SH | SOLE | 0 | 1,565,000 | 0 | 0 | ||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 21,513,500 | 850,000 | SH | SOLE | 0 | 850,000 | 0 | 0 | ||
ZAI LAB LTD | ADR | 98887Q104 | 961,186 | 31,309 | SH | SOLE | 0 | 31,309 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 103,721,000 | 5,150,000 | SH | SOLE | 0 | 5,150,000 | 0 | 0 |